药物对比
Linagliptin vs Pioglitazone
比较 Linagliptin（Tradjenta）与 Pioglitazone（Actos）治疗2型糖尿病。DPP-4与TZD作用、副作用、心力衰竭风险及适用性方面的差异。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing between a DPP-4 inhibitor and a thiazolidinedione for type 2 diabetes patients with insulin resistance or cardiovascular concerns.
结论
The preferred agent depends on patient-specific risks such as heart failure, weight, and renal function rather than one being inherently superior.
全部药物对比